Key facts
- Suvretta Capital Management is a hedge fund based in New York, New York with 3 tracked portfolio companies.
- Notable positions include VeraDermics (NYS: MANE), connectRN, Avalyn Pharma.
- The team roster lists 7 people.
- Suvretta Capital Management reports $7.9B in regulatory assets under management across 3 private funds, per its SEC Form ADV (2026-03).
About Suvretta Capital Management
Founded in 2011
Registered with the SEC
Form ADV · 2026-03 · CRD 165153- Regulatory AUM
- $7.9B
- Private fund assets
- $7.8B
- Private funds
- 3 · 3 hedge
- Staff
- 23
- Registered office
- NEW YORK, NY
- SEC status
- Approved
Discloses a disciplinary history on Form ADV.
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as SUVRETTA CAPITAL MANAGEMENT, LLC).
Free account
See the whole book
- ·Watchlist + alerts for Suvretta Capital Management's activity
Create free account
No card required
Portfolio, priced
3 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| VeraDermics (NYS: MANE) | Drug Discovery | $596.3M | — | |
| connectRN | — | $256.0M | — | |
| Avalyn Pharma | — | $155.0M | — |
Team
7 people on record — 7 with verified contacts
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked
- What companies does Suvretta Capital Management invest in?
- Suvretta Capital Management has 3 recorded portfolio companies, including VeraDermics (NYS: MANE), connectRN, Avalyn Pharma.
- What is Suvretta Capital Management's AUM?
- Suvretta Capital Management manages approximately $7.9B in assets.